Home » Topics » Regulatory

Regulatory
RSS

Sheffield and Inhale to develop inhaled migraine therapy

May 6, 2002

Zomig RM approved in Japan

May 3, 2002

Orphan Medical licenses rights to butamben

April 29, 2002

Faslodex approved in U.S. for tamoxifen-resistant breast cancer

April 29, 2002

MediGene submits MAA in Germany for Eligard 22.5 mg

April 26, 2002

Periostat approved in Austria and Finland

April 26, 2002

Prefilled syringe presentation of Copaxone launched

April 26, 2002

Xalatan approved in E.U. as first-line therapy for lowering IOP in glaucoma patients

April 24, 2002

Paxil CR launched in U.S.

April 23, 2002

Altocor filed for European marketing approval

April 22, 2002

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...